Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solu is a Finnish biotechnology and healthtech company that provides a real-time genomic database and analysis platform for microbes. The company focuses on preventing epidemics and managing infectious diseases by enabling rapid DNA sequencing analysis for clinical microbiology labs and hospitals. Its platform automates the identification of bacterial species, multi-locus sequence types (MLST), and antimicrobial resistance (AMR) genes, significantly reducing the time required for genomic surveillance. Solu's technology is currently utilized by research institutions and hospitals to monitor outbreaks and predict antibiotic susceptibility, particularly in complex cases like cystic fibrosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solu-Bio.